State of the Industry: Top Trends for Rural Healthcare Providers

Last updated May 6, 2026

Rural healthcare providers also demonstrated strong interest in technologies that have the potential to increase patient engagement, such as mobile apps and patient responsibility estimation tools.

Using an HRO Model in the Perioperative Suite: Your Nurses’…

May 18, 2026

The Business Value Of Improving Patient Experience

May 15, 2026

How Intelligent Workflow Technology Can Help Address…

May 14, 2026

Prev Next 1 of 149

Using an HRO Model in the Perioperative Suite: Your Nurses’…

May 18, 2026

The Business Value Of Improving Patient Experience

May 15, 2026

How Intelligent Workflow Technology Can Help Address…

May 14, 2026

Post Views: 297

The Harms of Overuse in Healthcare

Research-Driven Patient Statements Enhance the Collections Process

Leave A Reply

Articles

RadioMedix to Present at SNMMI 2026 and Mark 20 Years of Radiopharmaceutical Innovation

2026-05-28T14:42:30Z

Company’s SNMMI week activities highlight scientific progress and two decades of advancing precision nuclear medicine for patients with hard-to-treat cancers

Pharming Group announces results of 2026 Annual General Meeting of Shareholders

2026-05-28T14:40:00Z

Leiden, the Netherlands, May 28, 2026: Pharming Group (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) today announced that shareholders approved all proposals presented at its Annual General Meeting...

Fortis Life Sciences Expands AbNano® Portfolio with First VHH Library Derived from Peripheral Natural Killer Cells for Rapid Antibody Discovery

2026-05-28T14:33:00Z

The new AbNano® library enables VHH discovery against complex NK-cell-associated targets for engineered cell platforms and translational research

ProMIS Neurosciences to Participate in Upcoming Conferences in June

2026-05-28T14:13:28Z

CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today...

Serotonin Centers Opens in Lake Nona, Expanding Physician-Led Longevity Care into One of the Nation’s Leading Health Innovation Communities

2026-05-28T13:39:00Z

New Location Aligns with Growing Demand for Data-Driven Wellness, Hormone Optimization and Advanced Recovery Therapies

MMI Earns Gold Edison Award for Symani®, Recognized for Expanding Access to Life-Changing Surgical Treatment Options

2026-05-28T13:30:00Z

Symani honored for advancing lymphatic microsurgery – from treating lymphedema to enabling exploration of new disease pathways

Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant (ORSERDU®) in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

2026-05-28T13:30:00Z

FLORENCE, Italy and NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary...

Akari Therapeutics Discusses Breakthrough Potential of AKTX-101 and Novel Spliceosome-Modulating ADC Platform in Virtual Investor “What This Means” Segment Following ASCO Abstract Acceptance

2026-05-28T13:17:00Z

CEO Abizer Gaslightwala highlights promising ASCO data demonstrating synergy of AKTX-101 with adagasrib in KRAS-driven cancers

Range Impact Announces West Virginia Attorney and Business Advisor Michael Simon Has Joined the Company as a Strategic Advisor

2026-05-28T13:15:00Z

CLEVELAND, OHIO, May 28, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mine...

Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs

2026-05-28T13:10:38Z

NOT FOR DISSEMINATION INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness

2026-05-28T13:04:49Z

NEW YORK and LVIV, Ukraine, May 28, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering off-the-shelf allogeneic iNKT cell therapies for cancer and immune disorders, today...

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

2026-05-28T13:04:00Z

Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience

Syneos Health Appoints Greg Licholai as Chief Medical Officer to Advance Next-Generation Drug Development

2026-05-28T13:00:00Z

Further Strengthens Company’s Medical Depth and Therapeutic Expertise

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Circular Genomics for the Transformative Bio-Hermes-001 Study

2026-05-28T13:00:00Z

Collaboration to accelerate the investigation of Alzheimer’s disease biomarkers with early access to Bio-Hermes-001 data

Teladoc Health Expands Access to Care Through Walmart’s Better Care Services

2026-05-28T13:00:00Z

Walmart customers can now easily access Teladoc Health’s range of services, including virtual urgent care, dermatology, and nutrition services, with insurance benefit and cash-pay options

AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations

2026-05-28T13:00:00Z

NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable...

Disney and Philips bring together beloved storytelling and innovative technology to support kids undergoing MRI exams

2026-05-28T13:00:00Z

May 28, 2026For the first time, Disney stories and characters will be integrated into Philips Ambient Experience for MRI at medical facilities around the world to help create calmer, more...

Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation

2026-05-28T12:50:00Z

TEL AVIV, May 28, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that multiple abstracts...

SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum

2026-05-28T12:40:00Z

TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on...

FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY

2026-05-28T12:33:00Z

WEST PALM BEACH, FL and MINNETONKA, MN, May 28, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the “Company”) and LongevityFP Technologies, LLC. (“LFP”) today jointly announced a strategic...

Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

2026-05-28T12:30:00Z

WAYNE, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that on...